[1]
A. C. V. A. FILHO, “GAMMA-ORYZANOL HAS AN EQUIVALENT EFFICACY AS A LIPID-LOWERING AGENT COMPARED TO FIBRATE AND STATIN IN TWO DYSLIPIDEMIA MICE MODELS”, Int J Pharm Pharm Sci, vol. 6, no. 11, pp. 61–64, Nov. 2014.